Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Transfusion Reduction in Hip Fracture Surgery
NCT01714336Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in femoral neck fracture comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Number of Participants Who Received a Hospitalization Transfusion at 5 days. Started Sep 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
femoral neck fracture
Beyond the preview
Go deeper on NCT01714336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714336.